Reversible cardiotoxicity in a 54-year-old woman treated with trastuzumab
Background: We report a 54-year-old woman with an stage IIA (T2N0M0) RE and RP negative and HER2-positive ductal invasive breast cancer who developed a reversible cardiotoxicity associated with chemotherapy. After surgery, she received four cycles of doxorubicin and cyclophosfamide. Later, she used...
Guardado en:
Autores principales: | Martins,Sandro José, Modesto Dos Santos,Vitorino, Thommen Teles,Ludmila, Alves Leite,Viviane |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Médica de Santiago
2012
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000600010 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recaída de enfermedad de Hodgkin en adulto tras 17 años de remisión completa continua: Caso clínico
por: Osorio S,Guido, et al.
Publicado: (2003) -
Radio-quimioterapia postoperatoria en cáncer gástrico localmente avanzado
por: Garrido,Marcelo, et al.
Publicado: (2008) -
Quimiorradioterapia de neoadyuvancia en cáncer de vesícula biliar
por: de Aretxabala U,Xabier, et al.
Publicado: (2004) -
Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam
por: Phung HT, et al.
Publicado: (2020) -
Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study
por: Puhalla S, et al.
Publicado: (2016)